ArticleJournal of assisted reproduction and genetics2025
Mid-pregnancy circulating placental growth factor (PlGF) and obstetrical outcomes following nonovulatory and ovulatory frozen embryo transfer cycles.
Article in Journal of assisted reproduction and genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeWe compared serum placental growth factor (PlGF) concentration in pregnancies from ovulatory vs. non-ovulatory FET cycles and evaluated associations with obstetrical and neonatal outcomes.
methodsWe conducted a secondary analysis of a prospective single-center screening study at a large urban center in Canada where PlGF was performed between April 2020 and December 2022. Baseline characteristics were compared between FET ovulatory cycle and non-ovulatory cycle groups. We compared PlGF concentration in unadjusted and adjusted analyses using multivariable linear regression. Secondary outcomes were compared using chi square and Fisher exact tests for categorical variables and Wilcoxon rank sum tests for continuous variables.
resultsWe identified 340 patients, 246 (72.4%) in the non-ovulatory group and 94 (27.7%) in the ovulatory group. The median gestational age (IQR) at PlGF testing was 27.9 weeks (26.6-28.3) in the non-ovulatory group and 27.7 weeks (25.6-28.1) in the ovulatory group (p = 0.07). Univariable analysis comparing the difference in PlGF showed no association between groups [β - 51.7 (95% CI - 43.7-384.1), p = 0.44]. After adjusting for maternal age, race, parity, pre-pregnancy BMI, gestational diabetes, gestational age of PlGF test, donor egg cycle, and maternal and previous obstetrical comorbidities, the difference in PlGF concentration remained non-significant. Obstetrical and neonatal outcomes were similar between groups.
conclusionOur findings indicate no significant difference in either mid-pregnancy circulating PlGF concentration or obstetrical outcomes comparing successful FETs in ovulatory vs. non-ovulatory cycles. Larger-scale prospective research should be prioritized to further elucidate the role of PlGF in predicting the potential risk of adverse pregnancy outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.